Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Opinion in Lipidology
|
July 1, 2014
The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy
Handrean Soran, Jonathan D Schofield, Paul N Durrington
Frontiers in Pharmacology
|
November 4, 2015
Antioxidant properties of HDL
Handrean Soran, Jonathan D Schofield, Paul N Durrington
European Heart Journal
|
August 6, 2015
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment
Handrean Soran, Jonathan D Schofield, Paul N Durrington
Current Opinion in Lipidology
|
July 1, 2014
Lipoprotein (a): gene genie
Paul N Durrington, Jonathan D Schofield, Tarza Siahmansur, et al.
Current Opinion in Lipidology
|
May 24, 2016
Diabetic dyslipidaemia
Handrean Soran, Jonathan D Schofield, Safwaan Adam, et al.
Current Opinion in Lipidology
|
June 24, 2015
How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae
Handrean Soran, Jonathan D Schofield, Yifen Liu, et al.
Current Opinion in Cardiology
|
June 6, 2013
High-density lipoprotein cholesterol raising: does it matter?
Jonathan D Schofield, Michael France, Basil Ammori, et al.
Journal of Clinical Lipidology
|
August 12, 2014
A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report
Jonathan D Schofield, Yifen Liu, Michael W France, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 9, 2016
Diabetes Dyslipidemia
Jonathan D Schofield, Yifen Liu, Prasanna Rao-Balakrishna, et al.
Current Opinion in Lipidology
|
June 24, 2015
Unintended positive and negative effects of drugs on lipoproteins
Tarza J Siahmansur, Jonathan D Schofield, Shazli Azmi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Opinion in Lipidology
|
July 1, 2014
The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy
Handrean Soran, Jonathan D Schofield, Paul N Durrington
Frontiers in Pharmacology
|
November 4, 2015
Antioxidant properties of HDL
Handrean Soran, Jonathan D Schofield, Paul N Durrington
European Heart Journal
|
August 6, 2015
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment
Handrean Soran, Jonathan D Schofield, Paul N Durrington
Current Opinion in Lipidology
|
July 1, 2014
Lipoprotein (a): gene genie
Paul N Durrington, Jonathan D Schofield, Tarza Siahmansur, et al.
Current Opinion in Lipidology
|
May 24, 2016
Diabetic dyslipidaemia
Handrean Soran, Jonathan D Schofield, Safwaan Adam, et al.
Current Opinion in Lipidology
|
June 24, 2015
How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae
Handrean Soran, Jonathan D Schofield, Yifen Liu, et al.
Current Opinion in Cardiology
|
June 6, 2013
High-density lipoprotein cholesterol raising: does it matter?
Jonathan D Schofield, Michael France, Basil Ammori, et al.
Journal of Clinical Lipidology
|
August 12, 2014
A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report
Jonathan D Schofield, Yifen Liu, Michael W France, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 9, 2016
Diabetes Dyslipidemia
Jonathan D Schofield, Yifen Liu, Prasanna Rao-Balakrishna, et al.
Current Opinion in Lipidology
|
June 24, 2015
Unintended positive and negative effects of drugs on lipoproteins
Tarza J Siahmansur, Jonathan D Schofield, Shazli Azmi, et al.
Page
of 2